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genes, which encode enzymes that specifically degrade sulfated polysaccharides of marine algae, frequently occur in the Japanese population but are absent from the metagenomes of North American individuals [18] . On the basis of these reports, seaweed consumption appears to be associated with changes in the gut's bacterial environment.
Despite the long history of its intake, changes in the intestinal environment following the ingestion of wakame are unclear. Moreover, the effect of a long-term (over 2 wk) wakame ingestion on the frequency of defecation and on the composition of intestinal bifidobacteria has not been studied in detail. Hence, in the current study, the intestine-conditioning effect of wakame was evaluated in healthy adults with a tendency of constipation, by comparing the frequency of bowel movements, stool quantity and quality, and the composition of the intestinal microbiota before and after wakame intake. We also examined the possibility of using wakame as a prebiotic.
MATERIALS AND METHODS

Materials
Dried wakame (product name: FUERU WAKAME-CHAN® Sanriku), manufactured by Riken Food Co., Ltd., (Tokyo, Japan) was used; 4 g of dried wakame contains 1.42 g of fiber, 0.82 g of protein, 0.20 g of lipids, and 1.58 g of carbohydrates.
Subjects
The subjects were 22 healthy Japanese women aged 20 to 49 years, selected from among paid volunteers recruited by SOUKEN Co., Ltd. (Tokyo, Japan). They were all registered in the SOUKEN databank of untreated subjects, who, in a questionnaire filled out in advance of the study, declared that the frequency of their bowel movements was 3-5 times/wk. Individuals with possible food allergies, alcoholics, or ones with serious diseases were excluded.
Individuals periodically taking intestine-conditioning drugs, and regular users of drugs that might have an intestine-conditioning effect, were also excluded. Consequently, 37 individuals who fulfilled the criterion of low frequency of bowel movements underwent further screening to select the 22 study subjects.
The frequency of bowel movements of the 37 prospective subjects was evaluated based on their journal entries over the course of 1 wk, and their stool microbiota was evaluated in detail.
Finally, 22 individuals (mean age, 40±6.8 years) who fulfilled the criterion of low percentage of bifidobacteria in fecal bacteria were enrolled in the study.
Study design
The present clinical trial was designed as an open-label study to validate the effect of wakame consumption on the intestinal environment and bowel movements. The current study was approved by the Ethics Committee of the Shiba Palace Clinic and was conducted in accordance with the Declaration of Helsinki. The subjects were fully informed as to the content and method of the study, and provided written informed consent prior to the study.
The wakame intake schedule is shown in Figure 1 . After a 2 wk pre-intake period, each volunteer was administered wakame for 2 wk (4 g of dried wakame per day). The subjects were allowed to prepare it as per personal preference.
With respect to the general food intake, the subjects were asked to observe their habitual diet. Each subject reported each meal, and average daily nutritional intake per subject was calculated using Excel Eiyokun Ver.3.0. However, because the studied substance very likely affected the gut flora, other food products with similar effects were prohibited during the course of the study. During the entire study period, the subjects filled out a daily questionnaire about their diet, prescriptions, and health status. The subjects were also asked to complete a daily stool characteristics questionnaire.
The first fecal sample was collected before the subjects began the intake of wakame. The second sample was collected after a 2 week intake of wakame. 
Isolation of DNA from fecal samples
About 800 l of the fecal sample suspension preserved at 4°C was transferred to a tube containing zirconia beads, and the cells were disrupted using the FastPrep-24™ 5G cell disruptor (MP Biomedicals, Irvine, CA). After cooling on ice, the samples were centrifuged at 5000 rpm for 1 min. DNA was automatically extracted from the processed supernatant using a 12GC and GC series Magtration-MagaZorb DNA common kit 200N (Precision System Science, Chiba, Japan). The final concentration of the extracted DNA was adjusted to 10 ng/l.
Terminal restriction fragment length polymorphism (T-RFLP) analysis
The terminal restriction fragment length polymorphism (T-RFLP) analysis was performed as described by Nagashima et al. (2003) [19] . Briefly, the 16S rRNA gene was amplified using 
Analysis of the human fecal microbiota by next-generation sequencing (NGS)
Sequences of the 16S rRNA gene of human fecal bacteria were analyzed by next-generation sequencing (NGS) using the MiSeq system (Illumina, San Diego, CA) as previously described [20] and the dual-index method [21] . [20] . The PCR reaction conditions for amplification of DNA were as follows: initial denaturation at 98 °C for 2 min, followed by 35 cycles of annealing beginning at 65°C and ending at 55°C for 15 sec, and extension at 68° C for 30 sec. The annealing temperature was lowered 1 °C every cycle until it reached 55° C, which was maintained for the remaining cycles. PCR products were purified through a MultiScreen PCRu96 filter plate (Merck Millipore, USA). To prepare amplicon pool, purified products were quantified by real-time quantitative PCR (q-PCR) on a
Rotor-Gene Q quantitative thermal cycler using MightyAmp for Real-Time (SYBR Plus) [20] .
Barcoded amplicons were sequenced using the MiSeq Reagent kit v.3 (a paired-end, 2×284 bp cycle on the MiSeq system (600 cycles in total)) [20] .
The paired-end reads were concatenated using fastq-join with default option [22] . Only joined-reads that had quality value score of ≥ 20 for more than 99% of the sequence were extracted using FASTX-Toolkit [20; http://hannonlab.cshl.edu/fastx_toolkit/]. Chimeric sequences were deleted with usearch6.1 [23] .
Identification of bacteria from sequence reads was performed manually using the Ribosomal Database Project (RDP) Multiclassifier tool [24] , which is available from the RDP 0.5 g of L-cysteine hydrochloride, 15 g of sodium propionate, 10 g of galacto-oligosaccharide, and 15 g of agar) was prepared according to the manufacturer instructions and sterilized by autoclaving at 121°C for 15 min. All plates were incubated anaerobically at 37°C in jars, with anaerobic gas packs (Mitsubishi Gas Co., Ltd.) maintaining oxygen levels below 0.1%.
Statistical analysis
The data are presented as the mean ± standard deviation (SD 
RESULTS
Food and nutrient intake
Data for subject 1, who took a drug because of a cold, were excluded. The average daily nutrient intake per subject during each study period is summarized in Table 1 . Based on the subjects' testimonials, no significant differences in the average nutrient intake were observed except for the total fiber intake, which was significantly elevated during wakame administration. 
Effect of wakame intake on frequency of bowel movements, and stool volume and quality
The number of bowel movements, number of days with bowel movements, and stool volume significantly increased during wakame intake compared with the period before the intake (Table 2) . On the other hand, the shape and color of the stool (assessed using a scoring system) during the two study periods were not significantly different (Table 3) . Values are expressed as the mean ±SD (n=21). a) Stool volume was converted with size L of a chicken egg.
Significantly different from before intake period (**：P＜0.01 ***：P＜0.001; Student's t-test). 
Functional Foods in Health and
The analysis of fecal microbiota
We characterized fecal bacterial profiles according to T-RF patterns. The effect of wakame consumption on the composition of fecal microbiota is shown in Figure 2 . Bifidobacterium, Lactobacillales and Clostridium cluster XVIII levels were significantly higher after wakame consumption (P<0.05) than before. The increase in Bifidobacterium levels was observed in 17 out of 21 subjects (81% subjects). However, Bacteroides counts decreased significantly after wakame consumption (P<0.05). No significant change was observed in the counts of other bacteria after wakame intake. Significantly different from before intake period (n=21, *:P<0.05; Wilcoxon signed-rank test)
The analysis of fecal Bifidobacterium species by NGS
We next analyzed fecal microbiota species by NGS. Figure 3 shows the changes that occurred in fecal microbiota at the phylum level. After wakame intake, the proportion of Actinobacteria increased and the proportion of Bacteroidetes decreased The fecal counts of Bifidobacterium species, which T-RFLP analysis showed were significantly increased after wakame intake, were examined in more detail by NGS. The effect of wakame intake on the abundance of human fecal Bifidobacterium species is shown in Table   4 . Three Bifidobacterium species were detected before and after wakame intake.
Bifidobacterium longum was the species whose counts were significantly increased (P<0.05) after 2 wk of the wakame intake. Significantly different from before intake period (n=21, *:P<0.05, ***:P＜0.001, †：P＜0.1;
Wilcoxon signed-rank test). Values are expressed as the mean ±SD (n=21).
Significantly different from before intake period (*：P＜0.05; Wilcoxon signed-rank test).
The effect of wakame on the growth of B. longum
Viable counts of three species of Bifidobacterium (cultured in MRS medium) are presented in Table 5 . TOS medium contains trans-galactosylated oligosaccharide and is particularly suitable for growing bifidobacteria. All speies of Bifidobacterium grew in TOS medium. B. longum and B. bifidum showed stronger growth in MRS containing wakame powder than in MRS medium alone. Wakame powder in MRS media did not affect the growth of B. adolescentis; growth was similar in MRS containing wakame powder and MRS medium alone. The effect of wakame on the growth of B. longum is shown in Figure 4 . After a 7 d culture, no B. longum colonies were apparent on MRS medium that did not contain wakame, but the colony counts increased with increasing wakame concentration. The colony counts of B. longum significantly increased in a wakame dose-dependent manner. 
DISCUSSION
The current paper constitutes the first-ever report evaluating the effectiveness of seaweed in healthy subjects with a tendency for constipation, based on the state of bowel movements, stool quality, and stool microbiota composition. Stool volume and frequency of bowel movements significantly increased significantly after wakame intake (Table 2) . Moreover, bifidobacterial counts in the stool increased after wakame intake (Figure 4 , Table 4 ). These observations suggest that wakame may act like as a prebiotic.
In recent years, many people in Japan have been suffering from constipation because of the stress of daily life and intake of Western-style food. Many people who are considered healthy suffer from intestinal disorders, such as constipation, and the quality of life (QOL) is greatly associated with severity of constipation [25] . Therefore, maintaining good bowel movements and conditioning the intestinal environment are prerequisite for physical and mental health.
Pro-and prebiotics, e.g., Lactobacillus and dietary fiber, improve the bowel movements [26, 27] . Seaweed is a rich source of dietary fibers such as arginic acid, fucoidan and laminaran [28] . in the numbers of bifidobacteria after wakame intake and a significant decrease in the amount of faecal ammonia during alginate consumption [31] . In the current study, we demonstrated an increase in B. longum counts after wakame intake and an increase in the bifidogenic growthstimulating activity of wakame in vitro (Table 4 , Table 5 , Figure 4 ). Therefore, the wakame fiber may be used by bifidobacteria. However, in the current study, the subjects were administered only 4 g of wakame per day, i.e., 1.4 g of wakame fiber per day. It has been reported that 10 g alginate intake once a day for 2 weeks affects faecal microbiota [31] . Thus, it is possible that another factor stimulates bifidobacterial growth upon wakame intake. [32] . Bifidobacteria produce organic acids, which reduce the intestinal pH and create an acidic environment that regulates the growth of putrefactive bacteria [33] . Woting et al. (2015) reported that the ability of oligofructose to reduce obesity and improve glucose tolerance in gnotobiotic mice fed a high-fat diet is independent of the presence of B. longum, suggesting that B. longum plays a role in metabolic syndrome [34] . In this report, we demonstrated that wakame promotes growth of B. longum (Table 4 ). Wakame may prevent metabolic syndrome via a prebiotic function.
The percentage of Actinobacteria, to which Bifidobacterium belongs, significantly increased and the percentage of Bacteroidetes decreased (Figure 3 ). Compositional changes in gut microbiota in Japanese subjects with age have been reported [12] . In their report, the relative abundance of Actinobacteria decreased with age, and an increase in the relative abundance of Bacteroidetes was observed in subjects over 70 years old. Kato-Kataoka et al.
reported that the percentage of bacteria belonging to the phylum Bacteroidetes increased under the examination stress only in the placebo group compared with Lactobacillus casei-fermented milk group [35] . Wakame may affect human aging and QOL via the intestinal environment.
The human intestinal microbiota is impacted by various factors, e.g., the diet, environment, age, gender, and geographical and socioeconomic situation; among these, the diet has the most profound impact [36] . Seaweed is an important component of the daily diet in Japan, and over the centuries, seaweed has contributed to Japanese health. Prior to the present study, the ability of wakame to prevent metabolic syndrome in human has been suggested [9, 10] . The findings of the current study suggest that wakame may help to maintain an appropriate intestinal environment.
Further studies to determine functional constituent and assessment of durability of shift in microbiome and all remain to be solved.
CONCLUSION
The present study demonstrated for the first time that daily consumption of wakame affects in healthy subjects with intestinal environment. The possibility of using wakame as a prebiotic was indicated. Wakame may help to maintain an appropriate intestinal environment.
